NewGenIvf Group Ltd Class A (NIVF) Stock Price Quote, News…

Summary

Operating out of its headquarters in Bangkok, Thailand, NewGenIvf Group Limited specializes in delivering assisted reproductive services. The firm is committed to fulfilling the desire for family through a variety of fertility treatments. Its extensive service portfolio includes conventional in-vitro fertilization (IVF), egg donation, and surrogacy, all complemented by comprehensive ancillary care.

Website

www.nivf.global

Location

Bangkok, W1, TH

Phone66 2 116 9641

Employees87

CEOWing Fung Siu

SectorHealthcare

IndustryMedical - Care Facilities

IPO DateMar 18, 2022

Ask AI

Company overview

Business model, segments, and competition.

Peer comparison

Metrics vs closest competitors.

Guidance & outlook

Forward guidance and assumptions.

Bull vs bear case

Upside drivers and key risks.

Valuation snapshot

Multiples vs history and peers.

Competitive moat

Defensibility and market position.

Management track record

Leadership and capital allocation history.

How it makes money

A short diagram of the business model.

Latest Documents

Mentions in Filings

… . Mr. Tsang has served, from April 2021, as the Chief Executive Officer, and from July 2021, as the Chairman and Chief Financial Officer of A SPAC I Acquisition Corp, until it closed its business combination with NewGenIvf Group Limited in April 2024. Mr. Tsang also served as the Chief Executive Officer and Chairman of Model Performance Acquisition Corp. from March 2021 and July 2021 respectively, until it closed its business combination with Mul …
AParadise III Acquisition Corp.NewGenIvf Group Ltd Class A·S-1 - REGISTRATION STATEMENT·Q4 26·6 Nov
August 27, 2026 Wing Fung Alfred Siu Chief Executive Officer NewGenIvf Group Limited 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand Re: NewGenIvf Group Limited Registration Statement on Form F-1 Filed August 20, 2026 File No. 333-298442 Dear Wing Fung Alfred Siu: We have conducted a limited review of your registration statement and have the following comments. …
NewGenIvf Group Ltd Class A·LETTER - UPLOAD - Filing review upload·27 Aug·27 Aug
August 27, 2026 Wing Fung Alfred Siu Chief Executive Officer NewGenIvf Group Limited 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand Re: NewGenIvf Group Limited Registration Statement on Form F-1 Filed August 20, 2026 File No. 333-298442 Dear Wing Fung Alfred Siu: We have conducted a limited review of your registration statement and have the following comme …
NewGenIvf Group Ltd Class A·TEXT-EXTRACT - UPLOAD - Filing review upload·27 Aug·27 Aug
July 29, 2026 Wing Fung Alfred Siu Chief Executive Officer NewGenIvf Group Limited 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand Re: NewGenIvf Group Limited Draft Registration Statement on Form F-1 Submitted July 13, 2026 CIK No. 0001981662 Dear Wing Fung Alfred Siu: We have conducted a limited review of your draft registration statement and have the following …
NewGenIvf Group Ltd Class A·LETTER - UPLOAD - Filing review upload·29 Jul·29 Jul
July 29, 2026 Wing Fung Alfred Siu Chief Executive Officer NewGenIvf Group Limited 36/39-36/40, 13th Floor, PS Tower Sukhumvit 21 Road (Asoke) Khlong Toei Nuea Sub-district Watthana District, Bangkok 10110 Thailand Re: NewGenIvf Group Limited Draft Registration Statement on Form F-1 Submitted July 13, 2026 CIK No. 0001981662 Dear Wing Fung Alfred Siu: We have conducted a limited review of your draft registration statement and have the foll …
NewGenIvf Group Ltd Class A·TEXT-EXTRACT - UPLOAD - Filing review upload·29 Jul·29 Jul
… ount of up to aggregate $122,500. The initial tranche raised from JAK, together with the proceeds from non-redeeming ASCA shareholders, amounted to approximately US$2.5 million in gross proceeds. Upon the consummation of the business combination, ASCA changed its name to “NewGenIvf Group Limited.” (ticker symbol: “NIVF”). The shares of the combined company began trading on April 4, 2024, on Nasdaq Global Market under the new ticker symbol “NIVF”.
AParadise III Acquisition Corp.NewGenIvf Group Ltd Class A·DRS/A - Draft registration statement (amendment)·Q2 26·11 Jun

Key Stats

Trading

Px/Chg 1D$0.13 / +27.72%

Avg Volume4.06M

Beta1.53

Mkt Cap8.15K

FD Mkt Cap79.92K

Float

Shrs Out/Float63.17K / 62.46K

Short Float3.49%

Days to Cover1.00

Stock Repurchased$0.00

Current Valuation

EV3.47M

EV/EBITDA0.20

EV/Sales0.63

P/B0.00

P/S0.00

FCF Yield-204635.04%

ROE37.10%

ROA30.19%

Current Ratio3.12

Estimates

P/E0.00

Est P/E0.00

Est EPS185.40

Est PEG0.00

Valuation

Metric	5Yr Avg	Mar '22	Mar '23	Sep '24	Oct '25	Oct '26
PRICE-BASED RATIOS
Price / Earnings	-11,599,573.57	-58,084,947.69	72,025.70	15,079.70	-25.55	-0.00
Price / Sales	2,692.12	7,518.04	5,557.84	382.25	2.47	0.01
Price / Book Value	3,856.00	-39,899.16	58,666.40	525.56	-12.79	0.00
Price / Free Cash Flow	-6,469.60	21,857.31	-53,148.56	-1,055.13	-1.61	-0.00
ENTERPRISE VALUE METRICS
Enterprise Value	13,195.6	30,960.0	33,035.8	1,963.1	15.6	3.5
Enterprise Value / Sales	2,692.71	7,518.22	5,557.84	382.20	2.86	2.43
Enterprise Value / EBITDA	20,802.71	52,741.74	45,523.32	5,108.04	640.91	-0.48
Enterprise Value / EBIT	43,516.61	126,639.90	78,331.16	12,697.92	-85.45	-0.48

Financials

Full Financials

Millions USD	5Yr CAGR (%)	Dec '21	Dec '22	Dec '23	Dec '24	Dec '25
INCOME STATEMENT
Revenue	3.5%	4.1	5.9	5.1	5.4	4.7
Gross Income	-1.7%	1.0	1.5	1.7	1.8	1.0
EBITDA	107.3%	0.6	0.7	0.4	0.0	10.8
EBIT	155.1%	0.2	0.4	0.2	-0.2	10.3
Net Income	—	-0.0	0.5	0.1	-0.5	9.9
EPS (Diluted)	—	-0.00	62.52	12.44	-22.31	16.80
BALANCE SHEET
Cash & ST Inv	126.6%	0.0	0.0	0.1	0.5	0.8
Total Assets	119.4%	1.4	2.9	4.5	3.6	32.7
Total Liabilities	30.4%	2.3	2.8	1.2	5.1	6.7
Total Shareholder Equity	—	-0.8	0.6	3.7	-1.0	26.6
CASH FLOW
Net Operating Cash Flow	—	1.4	-0.5	-1.8	-8.3	-10.9
Cap Ex	331.6%	-0.0	-0.1	-0.1	-0.1	-5.7
Free Cash Flow	—	1.4	-0.6	-1.9	-8.3	-16.7

Enterprise Value Bridge

Millions USD		13 Nov '26
Price (As of 13 Nov '26)		0.22
Basic Shares		0.06
Market Cap		0.0
Diluted Shares		0.02
Fully Diluted Shares Outstanding		0.02
Fully Diluted Market Cap		0.0
+Consolidated Debt		1.6
−In-the-Money Convertible Debt		—
+Capital Leases		0.5
+Operating Leases		—
−Cash & Equivalents		-1.0
−Short-term Investments		-
+Total Preferred		-
−In-the-Money Convertible Preferred		—
−Investments in Unconsolidated Subs		—
+Non-Controlling Interest		-0.7
+Pension Liabilities		—
Enterprise Value		-0.1

Segment data

Revenue

by Geography

United States90%
Thailand7%
Cambodia3%
Hong Kong1%

Related companies